Dublin – Research and Markets ( ) has announced the addition of Global Markets Direct ‘s new report ” Cirrhosis – Pipeline Review, H1 2012″ to their offering.
Global Markets Direct’s, ‘Cirrhosis – Pipeline Review, H1 2012′, provides an overview of the Cirrhosis therapeutic pipeline. This report provides information on the therapeutic development for Cirrhosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cirrhosis. ‘Cirrhosis – Pipeline Review, H1 2012′ is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
– A snapshot of the global therapeutic scenario for Cirrhosis.
– A review of the Cirrhosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
– Coverage of products based on various stages of development ranging from discovery till registration stages.
– A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
– Coverage of the Cirrhosis pipeline on the basis of route of administration and molecule type.
– Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research development progress.
– Key discontinued pipeline projects.
– Latest news and deals relating to the products.
Key Topics Covered:
Global Markets Direct Report Coverage
An Overview of Pipeline Products for Cirrhosis
Cirrhosis Therapeutics under Development by Companies
Cirrhosis Therapeutics under